Andrea Small-Howard

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Andrea Small-Howard and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Andrea

Andrea Small-Howard

President

GB Sciences, Inc

Dr. Andrea Small-Howard has 25 years of scientific research and executive experience in the biopharma industry supervising research & development, manufacturing, and quality control in global divisions. Dr. Small-Howard has taken novel biological products from ideation through commercialization. She has been named an inventor on seventy+ patent applications, taken the lead in obtaining regulatory approvals from the U.S. Food and Drug Administration ("US FDA"), and orchestrated commercial licensing deals.

Talks About
#personalizedmedicine #biopharmaceuticals

Preferred Locations
#NorthAmerica

Speaking Engagements

Canna Pharma 2022

Paid

As US lawmakers inch closer to lifting the onerous restrictions on research into medicinal cannabis, the need for interdisciplinary collaboration between the pharmaceutical and cannabis industries has never been clearer, or more essential.

12-13 October 2022

Healthcare

6th Annual Cannabinoid-Derived Drug Development Summit

Paid

Welcome to the 6th Annual Cannabinoid-Derived Drug Development Summit: Fundamental Understanding of Cannabinoid Translation. This premier event brings together preclinical and clinical scientists, R&D leaders, and drug developers in the field of cannabinoid research. With a focus on navigating new FDA regulatory guidance, discovering novel cannabin

12-13 September 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Andrea Small-Howard

President

Speaking Engagements

Canna Pharma 2022

6th Annual Cannabinoid-Derived Drug Development Summit